DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 2709613
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2709613
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Mar 26, 2029 | Gilead Sciences Inc | SOVALDI | sofosbuvir |
➤ Sign Up | Sep 14, 2032 | Gilead Sciences Inc | HARVONI | ledipasvir; sofosbuvir |
➤ Sign Up | Mar 26, 2029 | Gilead Sciences Inc | EPCLUSA | sofosbuvir; velpatasvir |
➤ Sign Up | Mar 26, 2029 | Gilead Sciences Inc | HARVONI | ledipasvir; sofosbuvir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |